Obtenga las últimas noticias sobre las acciones de InMed Pharmaceuticals con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de INM

Últimas noticias sobre

InMed Pharmaceuticals

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The Company's operations consist of two operating and reportable segments, the InMed Pharma segment and the BayMedica Commercial segment. The InMed Pharma segment is largely organized around the research and development of small molecule pharmaceuticals drug candidates and the BayMedica Commercial segment is largely organized around manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease.

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

ANAB

ASST

CCLD

Cardio Diagnostics Holdings Inc. - Common stock

CDIO

DWTX

HSDT

HUBC

LSTA

NEHC

NFLX

SEPN

STFS

USEG

Netflix sorprende con un aumento en suscriptores y mejores pronósticos. Descubre también los mayores ganadores y perdedores del premercado.

Acciones de Netflix se disparan alrededor del 15%; 20 acciones que se están moviendo en el premercado de EE.UU.

InMed Pharmaceuticals Inc. - Common Shares

InMed Pharmaceuticals Inc

InMode Ltd

INmune Bio Inc

iShares Intermediate Muni Income Active ETF

Rokeby Resources Ltd

Press Releases

InMed's INM-901 Significantly Reduces Neuroinflammation in Alzheimer's Disease Ex Vivo Study

InMed Pharmaceuticals Announces $5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

InMed Pharmaceuticals Announces Closing of $5 Million Private Placement Priced At-the-Market under Nasdaq Rules

Life Science Virtual Investor Forum Agenda Announced for September 18th

InMed to Present at the Life Sciences Virtual Investor Forum September 18th, 2025

Life Sciences Virtual Investor Forum: Presentations Now Available for Online Viewing

ACUT

DRMA

HMTXF

INNMF

PETV

SIGY

TSXV:HEM

UEEC

Akanda

Aspire Biopharma Holdings, Inc. - Warrant

Aspire Biopharma Hldgs

Biofrontera

Clearmind Medicine

CNS Pharma

China Pharma Holding

Enveric Biosciences

Evoke Pharma

Impact BioMedical

Lexaria Bioscience

NovaBay Pharmaceuticals, Inc. Common Stock

NovaBay Pharmaceuticals

NLS Pharmaceutics

Nutriband

Purple Biotech Ltd. - American Depositary Shares

Purple Biotech

PainReform

Q/C Technologies

Redhill Biopharma Ltd. - American Depositary Shares

Redhill Biopharma

Reviva Pharmaceuticals Holdings, Inc. - Warrants

Reviva Pharmaceuticals

Sonoma Pharmaceuticals, Inc. - Common Stock

Sonoma Pharmaceuticals

SciSparc

60 Degrees Pharmaceuticals, Inc. - Common Stock

60 Degrees

XORTX Therapeutics

Screenshot 2024-08-27 at 5.44.40 PM

Biotech

General

InMed Demonstrates Encouraging Data For Its Cannabinoid INM-089 In Treating Dry AMD, An Ocular Disease With Rising Patient Numbers As National Population Ages

Screenshot 2024-07-18 at 5.31.04 PM

Cannabis

The Rising Importance Of Minor Cannabinoids In The Growing Edible Market

Screenshot 2024-05-06 at 5.34.20 PM

InMed (NASDAQ: INM) Developing Cannabinoids Analogs To Treat Alzheimer&#39;s – New Studies Showcase INM-901&#39;s Therapeutic Abilities

Comments

InMed Pharmaceuticals Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL